PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
49.06
Similar ESG score to TGTX's 48.40. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
63.54
Environmental score 1.1-1.2x TGTX's 58.02. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
31.02
Social score below 80% of TGTX's 49.20. Jim Chanos would check for potential social license and litigation risks.
52.63
Governance score exceeding 1.2x TGTX's 37.99. Mohnish Pabrai would examine if this governance advantage creates sustainable competitive advantages through better decision-making.